Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Radiol. Jun 28, 2012; 4(6): 258-264
Published online Jun 28, 2012. doi: 10.4329/wjr.v4.i6.258
Table 1 Patient characteristics n (%)
All patients (n = 18)Ischemic (n = 2)Non-ischemic (n = 16)P-value
Male sex10 (56)2 (100)8 (50)0.32
Age (yr)56 ± 1367.5 ± 14.855.2 ± 12.30.86
Hypertension16 (89)2 (100)14 (88)1.00
Diabetes mellitus6 (33)2 (100)4 (25)0.10
Hyperlipidemia11 (61)2 (100)9 (56)0.50
Tobacco use3 (17)0 (0)3 (19)1.00
Body mass index27.9 ± 4.530.3 ± 5.428.3 ± 4.60.26
Creatinine clearance83.5 ± 29.460.4 ± 6.686.3 ± 29.90.052
Baseline medications
Lasix13 (72)2 (100)11 (69)1.00
Beta blocker18 (100)2 (100)16 (100)NS
ACE inhibitor/angiotensin receptor blocker17 (94)2 (100)15 (94)1.00
Aldactone4 (22)0 (0)4 (25)1.00
Digoxin3 (17)1 (50)2 (13)0.31
Statin use11 (61)2 (100)9 (56)0.50
Aspirin12 (67)2 (100)10 (63)0.53
Echocardiography
LV EF22.8 ± 8.617.5 ± 3.523.4 ± 8.90.33
Regional wall motion abnormalities12 (67)2 (100)10 (63)0.53
Valvular abnormalities6 (33)0 (0)6 (38)0.53
Table 2 Coronary computed tomography angiography parameters
All patients (n = 18)Ischemic(n = 2)Non-ischemic (n = 16)P-value
Sublingual nitroglycerin18 (100)2 (100)16 (100)NS
Intravenous β-blocker3 (17)0 (0)3 (19)1.00
Contrast amount91 ± 1781 ± 1593 ± 170.33
Contrast rate6 ± 0.55.5 ± 0.76.1 ± 0.40.33
Average heart rate75 ± 1668 ± 1176 ± 160.64
Calcium score138 ± 330789 ± 83957 ± 1140.03
LV EDV198 ± 87163 ± 47203 ± 910.72
LV EF37 ± 1917 ± 440 ± 190.09